U.S. pharma giant copyright scrapped two experimental weight loss products last 12 months—a the moment-daily capsule, lotiglipron, resulting from elevated liver enzymes plus a two times-day-to-day tablet, danuglipron, due to sturdy Unwanted side effects—but CEO Albert Bourla has mentioned the company is decided to “Enjoy and earn” inside th